Skip to content

Impact of rTMS on theory of mind and executive function in major depressive disorder and its correlation with BDNF: a randomized, double blind, sham-controlled trial

Effect of repetitive transcranial magnetic stimulation on serum BDNF level and cognitive function in patients with depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044633
Enrollment
Unknown
Registered
2021-03-25
Start date
2018-02-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive disorder

Interventions

Active rTMS Group:High-frequency Repetitive Transcranial Magnetic Stimulation (rTMS):
Sham rTMS Group:Pseudo stimulation with rTMS instrument

Sponsors

Shanghai Pudong New Area Mental Health Center, Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Patients meeting the DSM-5 diagnostic criteria for depression; 2. Aged 18 to 70 years old; 3. Hamilton Depression Scale (HAND-17) score >= 24; 4. Only escitalopram was used at a dose of 20mg per day; 5. Certain visual and auditory resolution without understanding disorders; 6. Capacity to independently complete the self-test scale; 7. Education above primary school; 8. Both patients and guardians agreed to participate in the study and signed the informed informed consent.

Exclusion criteria

Exclusion criteria: 1. History of severe physical disease or brain organic disease; 2. History of brain injury or head surgery; 3. History of metal implantation in the body; 4. Patients who had been treated with MECT or failed to receive rTMS within one month; 5. History of epilepsy and drug dependence; 6. Patients who were combined with other antidepressants or drug dose changes during the observation period; 7. Dementia/developmental delay diagnosis with behavioral disorder.

Design outcomes

Primary

MeasureTime frame
WCST;brain-derived neurotrophic factor;FEIT;Hinting Task;

Countries

China

Contacts

Public ContactXirong Sun

Shanghai Pudong New Area Mental Health Center, Tongji University School of Medicine

sunxirong@163.com+86 13917639849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026